4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-012428
Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Graham Juan Chief Financial Officer | 2023-02-21 | Grant or award | +25,000 | 72,962 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Graham Juan Chief Financial Officer | 2023-02-21 | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…